|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues from research and development collaborations | |||||
| Other income | |||||
| Total revenues and other income | |||||
| Operating expenses | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expenses | |||||
| Total operating expenses | |||||
| Operating result | |||||
| Financial income | |||||
| Financial expenses | |||||
| Net finance result | |||||
| Result before income taxes | |||||
| Income taxes | |||||
| Net result, attributable to shareholders | |||||
| Other comprehensive result | |||||
| Items that will not be reclassified to profit or loss | |||||
| Remeasurement of net pension liabilities | |||||
| Items that are or may be reclassified subsequently to profit or loss | |||||
| Exchange differences on translating foreign operations | |||||
| Other comprehensive result, net of tax | |||||
| Total comprehensive result, attributable to shareholders | |||||
| Basic net result per share (in CHF per share) | |||||
| Diluted net result per share (in CHF per share) |
Loading...